节点文献

抗感颗粒治疗小儿流行性感冒120例多中心随机对照双盲临床研究

A Multicenter Randomized Controlled Double-blind Clinical Trial on Kanggan Keli(抗感颗粒) in Treating 120 Cases of Infantile Influenza

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 胡思源李新民耿福能沈咏梅冀晓华冯自威何文郑广力吴玥邵荣昌杜永刚

【Author】 HU Siyuan;LI Xinmin;GENG Funeng;SHEN Yongmei;JI Xiaohua;FENG Ziwei;HE Wen;ZHENG Guangli;WU Yue;SHAO Rongchang;DU Yonggang;First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine;Chengdu Gaoxin Haoyisheng First Hospital;Xiyuan Hospital,China Academy of Chinese Medical Sciences;Luohe Hospital of Chinese Medicine;Second Affiliated Hospital of Xi’an Medical College;Changchun Children’s Hospital;Harbin Hospital of Chinese Medicine;Ezhou Central Hospital;Changzhi People’s Hospital;

【机构】 天津中医药大学第一附属医院成都高新好医生第一医院中国中医科学院西苑医院漯河市中医院西安医学院第二附属医院长春市儿童医院哈尔滨市中医医院鄂州市中心医院长治市人民医院

【摘要】 目的评价抗感颗粒治疗小儿流行性感冒的疗效及安全性。方法采用随机、双盲双模拟、平行对照、多中心临床试验方法,将240例患儿分为治疗组和对照组各120例,治疗组口服抗感颗粒及利巴韦林颗粒模拟剂,对照组口服抗感颗粒模拟剂及利巴韦林颗粒,两组疗程均为7天,疗程中临床痊愈者,随时停药,按完成病例处理。观察两组患儿完全退热时间、临床痊愈时间、主要症状(发热、头痛、鼻塞、流涕、咽痛)的曲线下面积(AUC)以及中医证候疗效与安全性,同时采用全分析集分析(FAS)与符合方案分析集分析(PDS)。结果完全退热时间FAS治疗组中位时间为32.00 h,对照组为72.00 h(P<0.01)。临床痊愈时间FAS治疗组中位时间为56.00 h,对照组为80.00 h,PPS与FAS结果相近,两组比较差异有统计学意义(P<0.01)。治疗组患儿发热、咽痛AUC面积治疗组小于对照组(P<0.01)。PPS与FAS结果一致。两组患儿中医证候疗效比较:FAS治疗组总有效率100%,愈显率92.50%。对照组分别为91.67%及72.50%。PPS治疗组总有效率100%,愈显率93.40%;对照组分别为91.26%及73.79%。治疗组总有效率及愈显率均高于对照组(P<0.01)。PPS与FAS结果一致。两组患儿均未出现不良反应。结论抗感颗粒治疗小儿流行性感冒疗效优于利巴韦林颗粒,且安全性好。

【Abstract】 Objective To evaluate the curative effect and safety of Kanggan Keli in treating infantile influenza.Methods A multicenter randomized,double-blind,double simulation,parallel control clinical trial was designed.Two hundred and forty children with influenza were divided into a treatment group( 120 cases) and a control group( 120 cases). The treatment group was given oral Kanggan Keli and ribavirin particle analogue; while the control group was given oral Kanggan Keli analogue and ribavirin particle. The course in both groups was 7 days. During the course,medication was stopped at any time once the patient was recover,which was processed as the completed case.It was examined in both groups that time for body temperature return normal,time for clinical recovery,area under curve( AUC) of main symptoms( fever,headache,nasal obstruction,nasal discharge and sore throat),and Chinese medicine syndrome effect and safety. Meanwhile,full analysis set( FAS) and per protocol set( PPS) analysis was adopted. Results The median time for body temperature return to normal by FAS was 32. 00 h in the treatment group,and 72. 00 h in the control group( P < 0. 01). The median time for clinical recovery by FAS was 56. 00 h in the treatment group,and 80. 00 h in the control group. The result of PPS was similar to that of FAS. There was significant difference between the two groups( P < 0. 01). AUC of fever and sore throat in the treatment group was smaller than that in the control group( P < 0. 01). The result of PPS and FAS was similar. For Chinese medicine syndrome effect,the total effective rate and the cured and markedly effective rate by FAS was 100% and 92. 50%,respectively in the treatment group,and 91. 67% and 72. 50% respectively in the control group; the total effective rate and the cured and markedly effective rate by PPS was 100% and 93. 40%,respectively in the treatment group,and 91. 26% and73. 79% respectively in the control group. The total effective rate and the cured and markedly effective rate in the treatment group were both higher than those in the control group( P < 0. 01). The result of PPS and FAS was similar.No side effect was found in both groups. Conclusion The effect of Kanggan Keli in treating infantile influenza seems better than ribavirin particle,with good safety.

  • 【文献出处】 中医杂志 ,Journal of Traditional Chinese Medicine , 编辑部邮箱 ,2018年06期
  • 【分类号】R272
  • 【被引频次】22
  • 【下载频次】578
节点文献中: 

本文链接的文献网络图示:

本文的引文网络